CDK Global, Inc. (NASDAQ:CDK) registered a 3.16% increase, still its new closing price is 60.36% up from the company’s 1 year high of 63.30.It posted 3.08% gains in previous 5 sessions and is now the subject of 3 analysts who together assign a hold rating on stock. 1 of Wall Street analysts have an underperform rating; the 0 sells versus 1 buy or better ratings. The 6 stock analysts following this company have an average price target at $59.75, with individual PT in the $53.00-$65.00 range. The shares moved at $64.01, implying that brokerage firms see shares gaining about 43.52% in twelve months time.

CDK Global, Inc. (CDK) SEC Form 4 News

The stock is getting much attention these days as insiders are offloading shares while they posted a 7.24% rise year to date. A VP & President, ARNA at CDK Global, Inc. (CDK) offloaded shares in a transaction closed on Wednesday June 01, 2016. Karp Robert N. sold 27,573 shares in the company at $55.12 each and collected $1,519,001 in proceeds. Karp Robert N. now owns 54,627 shares in the company after this transaction. A VP & President, ARNA in the company, Karp Robert N., disclosed a transaction on Thursday February 12, 2015 that ended up generating $2,553,000 from the sale of 55,146 shares at $46.3 per share.

CDK Global, Inc. (NASDAQ:CDK) Upcoming Results on Tap

CDK Global, Inc. will next provide financial results for the September 2017 quarter. Stock analysts expect it to report per-share earnings of $0.70 in that period. Sales during the quarter are predicted to arrive at $576.45 million.

Earnings surprise history: Last quarter, the company posted approximately $550.7 million in revenue and EPS of $0.60. The mean forecast was for $538.63 million and $0.53 a share, respectively. One quarter earlier, revenue for the stock was at $542.2 million, with earnings at $0.49/share.

CDK Global, Inc. (CDK) Brokerage Update

CDK Global, Inc. (CDK) is in JP Morgan’s research list so their analyst rating change is noteworthy. These shares were upgraded to Neutral from Underweight by JP Morgan, according to news reported on Wednesday April 06, 2016.Another important research note was issued by Barrington Research on Thursday February 04, 2016.The firm upgraded CDK to Outperform from Mkt Perform. Over the last six months and over the last three months, the shares of CDK Global, Inc. (CDK), have changed 9.85% and 17.90%, respectively.